Helix BioPharma (TSE:HBP) Shares Cross Below 50 Day Moving Average – Here’s What Happened
by Teresa Graham · The Cerbat GemHelix BioPharma Corp. (TSE:HBP – Get Free Report)’s share price passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$1.87 and traded as low as C$1.82. Helix BioPharma shares last traded at C$1.88, with a volume of 505 shares traded.
Helix BioPharma Trading Up 3.3%
The company has a market cap of C$143.59 million, a P/E ratio of -31.33 and a beta of 0.38. The stock’s 50 day moving average is C$1.87 and its 200-day moving average is C$2.16. The company has a current ratio of 0.04, a quick ratio of 1.04 and a debt-to-equity ratio of 2.34.
About Helix BioPharma
Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today’s hardest-to-treat cancers. The Company’s pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today’s front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix’s next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery.